CTLA-4 blockade drives loss of Treg stability in glycolysis-low tumours
Roberta Zappasodi(Cornell University), Taha Merghoub(Weill Cornell Medicine)
Cited by 389
Related Papers
Pharmacologic LDH inhibition redirects intratumoral glucose uptake and improves antitumor immunity in solid tumor models
|Journal of Clinical Investigation|2024|65
Intermittent MEK Inhibition with GITR Costimulation Rescues T-cell Function for Increased Efficacy with CTLA-4 Blockade in Solid Tumor Models
|Cancer Immunology Research|2024|7
APR-246 increases tumor antigenicity independent of p53
|Life Science Alliance|2023|5